Odpornosc przeciw zakazeniu wirusem influenzy koni

• Autorzy: Purzycka M , Rozek W. , Zmudzinski J.F.

Warianty tytułu

EN

Immunity against equine influenza virus infection

• Języki publikacji: PL

Abstrakty

EN

Influenza virus plays an important role in respiratory diseases in horses. Equine influenza virus is represented by two different serotypes: H7N7 and H3N8. The strain H7N7 has not been isolated since 1980 and H3N8 circulates in the equine population throughout most of the world. For preventive and prophylactic measures inactivated and subunit vaccines are most commonly used. Contrary to natural infections, traditional vaccines induce neither cytotoxic lymphocytes T nor mucosal antibodies and they do not provide enduring immunity. There is also the difference in the immune response as the natural infection induces IgA, IgGa and IgGb antibodies whereas the traditional vaccines induce IgGc and IgG(T) and no IgA. The low efficacy of the traditional vaccines also depends on an antigenic drift of the surface glycoprotein - hemagglutynin.

Słowa kluczowe

PL

odpowiedz immunologiczna; influenza koni; odpowiedz humoralna; szczepienia ochronne; wirus influenzy koni; odpornosc zwierzat; chorobotworczosc; choroby zwierzat; konie

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 12
• Opis fizyczny: s.1519-1521,tab.,bibliogr.

Twórcy

autor

Purzycka M

• Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy

autor

Rozek W.

autor

Zmudzinski J.F.

Bibliografia

• 1.Cox R. J., Brokstad K. A., Ogra P.: Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live attenuated influenza vaccines. Scand. J. Immunol. 2004, 59, 1-15.
• 2.Daly J. M., Newton J. R., Mumford J. A.: Current perspectives on control of equine influenza. Vet. Res. 2004, 35, 411-423.
• 3.Daly J. M., Whitwell K. E., Miller J., Dowd G., Cardwell J. M., Smith K. C.: Investigation of equine influenza cases exhibiting neurological disease: coincidence or association? J. Comp. Path. 2006, 134, 231-235.
• 4.de Jong J. C., Rimmelzwaan G. F., Fouchier R. A. M., Osterhaus A. D. M. E.: Influenza virus: a master of metamorphosis. J. Infect. 2000, 40, 218-228.
• 5.Fouchier R. A. M., Osterhaus A. D. M. E., Brown I. H.: Animal influenza virus surveillance. Vaccine 2003, 21, 1754-1757.
• 6.Hannant D., Jessett D. M., O'Neil T., Sundquist B., Mumford J. A.: Nasopharyngeal, tracheobronchial and systemic immune responses to vaccination and aerosol infection with equine-2 influenza A virus (H3N8). Proc. Fifth Internat. Conf., Equine Infectious Diseases. University Press of Kentucky, Lexington 1987, s. 66-73.
• 7.Hannant D., Mumford J. A.: Virus Infection of Equines. Elsevier Science Publishers, Amsterdam 1996, 287-288.
• 8.Holmes M. A., Townsend H. G., Hussey S., Breathnach C., Barnett C., Holland R., Lunn D. P.: Immune responses to commercial equine vaccines. Int. Vet. Inf. Serv. 2003, P0630.1103.
• 9.Horohov D. W.: Immunology of the equine lung. Int. Vet. Inf. Serv. 2004, B0303.0804.
• 10.Minke J. M., Audonnet J.-Ch., Fischer L.: Equine viral vaccines: the past, present and future. Vet. Res. 2004, 35, 425-443.
• 11.Nelson K. M., Schram B. R., McGregor M. W., Sheoran A. S., Olsen C. W., Lunn D. P.: Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 1998, 16, 1306-1313.
• 12.Newton J. R., Lakhani K. H., Wood J. L. N., Baker D. J.: Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine. Prev. Vet. Med. 2000, 46, 129-141.
• 13.Paillot R., Hannant D., Kydd J. H., Daly J. M.: Vaccination against equine influenza: Quid novi? Vaccine 2006, 24, 4047-4061.
• 14.Palese P.: Making better influenza virus vaccines? Emerg. Infect. Dis. 2006, 12, 61-65.
• 15.Park A. W., Wood J. L., Newton J. R., Daly J., Mumford J. A., Grenfell B. T.: Optimising vaccination strategies in equine influenza. Vaccine 2003, 21, 2862- -2870.
• 16.Ramsay A. J., Husband A. J., Ramshaw I. A., Bao S., Matthaei K. I., Koehler G., Kopf M.: The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994, 264, 561-563.
• 17.Roitt I., Brostoff J., Male D.: Immunologia. Wyd. Lekarskie PZWL, Warszawa, Wyd. Medyczne Słotwiñski Verlag, Bremen 2000, 116.
• 18.Slater J., Hannant D.: Equine immunity to viruses. Vet. Clin. North. Am. Equine Pract. 2000, 16, 49-68.
• 19.Soboll G., Horohov D. W., Aldridge B. M., Olsen C. W., McGregor M. W., Drape R. J., Macklin M. D., Swain W. F., Lunn D. P.: Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination. Vet. Immunol. Immunopathol. 2003, 94, 47-62.
• 20.Steinbach F., Deeg C., Mauel S., Wagner B.: Equine immunology: offspring of the serum horse. Trends Immunol. 2002, 23, 223-225.
• 21.Timoney P. J.: Equine influenza. Comp. Immmun. Microbiol. Infect. Dis. 1996, 19, 205-211.
• 22.Wilson W. D.: Equine influenza. Vet. Clin. North. Am. Equine Pract. 1993, 9, 257-282.
• 23.Yates P., Mumford J. A.: Equine influenza vaccine efficacy: the significance of antigenic variation. Vet. Microbiol. 2000, 74, 173-177.
• 24.Zaleska M., Anusz K., Kita J.: Wpływ immunizacji przeciw influenzie koni na parametry odporności komórkowej. Medycyna Wet. 1995, 51, 90-93.